On June 8, 2026, Jaguar Health, Inc. held its Annual Meeting where stockholders approved five proposals, including the election of John Micek III as a director and a securities purchase agreement with C/M Capital for over 19.99% of shares. A total of 7,169,152 out of 14,044,277 shares were voted, showing significant engagement from shareholders.